menu ☰
menu ˟

Baricitinib shows higher efficacy than methotrexate in patients with RA

12 Oct 2016
First-line baricitinib alone showed higher efficacy and similar safety compared with methotrexate for patients with rheumatoid arthritis, according to a recent phase 3 trial.“The take-home points are: Baricitinib is as effective as monotherapy as i...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.